Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROKIDNEY CORP. Director's Dealing 2023

Jan 18, 2023

32485_dirs_2023-01-18_368a9e9d-ca85-4654-804e-4a3c003b4488.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROKIDNEY CORP. (PROK)
CIK: 0001850270
Period of Report: 2023-01-16

Reporting Person: Weger Mary (Chief People Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-01-16 Employee stock option (right to buy) $8.43 A 185000 Acquired 2033-01-16 Class A Ordinary Shares (185000) Direct

Footnotes

F1: The option vests in substantially equal monthly installments over the four year period beginning on January 16, 2023.